The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Empagliflozin API Market Research Report 2024
Synopsis
Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid.
The global Empagliflozin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Empagliflozin API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Empagliflozin API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Empagliflozin API include Piramal Enterprises Limited, Metrochem API Private Limited, ZCL Chemicals Limited, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikal, Morepen Laboratories and Zhejiang Huahai Pharmaceutial. Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Empagliflozin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Empagliflozin API.
Report Scope
The Empagliflozin API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Empagliflozin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Empagliflozin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Piramal Enterprises Limited
Metrochem API Private Limited
ZCL Chemicals Limited
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Hikal
Morepen Laboratories
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Lupin Ltd
Biocon Limited
Mehta API Pvt. Ltd
Danesh Kimia Pharmed
Shandong Haohong Biotechnology Co., Ltd.
Boryung Pharmaceutical Co., Ltd
Ami Lifesciences
Jiangsu Yutian Pharmaceutical Co., Ltd.
SGMR Pharmaceuticals
Kopran Limited
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Empagliflozin Tablets
Others
Production by Region
India
China
South Korea
Israel
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Empagliflozin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Empagliflozin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Empagliflozin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid.
The global Empagliflozin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Empagliflozin API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Empagliflozin API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Empagliflozin API include Piramal Enterprises Limited, Metrochem API Private Limited, ZCL Chemicals Limited, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikal, Morepen Laboratories and Zhejiang Huahai Pharmaceutial. Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Empagliflozin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Empagliflozin API.
Report Scope
The Empagliflozin API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Empagliflozin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Empagliflozin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Piramal Enterprises Limited
Metrochem API Private Limited
ZCL Chemicals Limited
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Hikal
Morepen Laboratories
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Lupin Ltd
Biocon Limited
Mehta API Pvt. Ltd
Danesh Kimia Pharmed
Shandong Haohong Biotechnology Co., Ltd.
Boryung Pharmaceutical Co., Ltd
Ami Lifesciences
Jiangsu Yutian Pharmaceutical Co., Ltd.
SGMR Pharmaceuticals
Kopran Limited
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Empagliflozin Tablets
Others
Production by Region
India
China
South Korea
Israel
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Empagliflozin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Empagliflozin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Empagliflozin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Empagliflozin API Market Overview
1.1 Product Definition
1.2 Empagliflozin API Segment by Type
1.2.1 Global Empagliflozin API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Empagliflozin API Segment by Application
1.3.1 Global Empagliflozin API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Empagliflozin Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Empagliflozin API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Empagliflozin API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Empagliflozin API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Empagliflozin API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Empagliflozin API Production Market Share by Manufacturers (2019-2024)
2.2 Global Empagliflozin API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Empagliflozin API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Empagliflozin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Empagliflozin API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Empagliflozin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Empagliflozin API, Product Offered and Application
2.8 Global Key Manufacturers of Empagliflozin API, Date of Enter into This Industry
2.9 Empagliflozin API Market Competitive Situation and Trends
2.9.1 Empagliflozin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Empagliflozin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Empagliflozin API Production by Region
3.1 Global Empagliflozin API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Empagliflozin API Production Value by Region (2019-2030)
3.2.1 Global Empagliflozin API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Empagliflozin API by Region (2025-2030)
3.3 Global Empagliflozin API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Empagliflozin API Production by Region (2019-2030)
3.4.1 Global Empagliflozin API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Empagliflozin API by Region (2025-2030)
3.5 Global Empagliflozin API Market Price Analysis by Region (2019-2024)
3.6 Global Empagliflozin API Production and Value, Year-over-Year Growth
3.6.1 India Empagliflozin API Production Value Estimates and Forecasts (2019-2030)
3.6.2 China Empagliflozin API Production Value Estimates and Forecasts (2019-2030)
3.6.3 South Korea Empagliflozin API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Israel Empagliflozin API Production Value Estimates and Forecasts (2019-2030)
4 Empagliflozin API Consumption by Region
4.1 Global Empagliflozin API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Empagliflozin API Consumption by Region (2019-2030)
4.2.1 Global Empagliflozin API Consumption by Region (2019-2024)
4.2.2 Global Empagliflozin API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Empagliflozin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Empagliflozin API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Empagliflozin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Empagliflozin API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Empagliflozin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Empagliflozin API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Empagliflozin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Empagliflozin API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Empagliflozin API Production by Type (2019-2030)
5.1.1 Global Empagliflozin API Production by Type (2019-2024)
5.1.2 Global Empagliflozin API Production by Type (2025-2030)
5.1.3 Global Empagliflozin API Production Market Share by Type (2019-2030)
5.2 Global Empagliflozin API Production Value by Type (2019-2030)
5.2.1 Global Empagliflozin API Production Value by Type (2019-2024)
5.2.2 Global Empagliflozin API Production Value by Type (2025-2030)
5.2.3 Global Empagliflozin API Production Value Market Share by Type (2019-2030)
5.3 Global Empagliflozin API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Empagliflozin API Production by Application (2019-2030)
6.1.1 Global Empagliflozin API Production by Application (2019-2024)
6.1.2 Global Empagliflozin API Production by Application (2025-2030)
6.1.3 Global Empagliflozin API Production Market Share by Application (2019-2030)
6.2 Global Empagliflozin API Production Value by Application (2019-2030)
6.2.1 Global Empagliflozin API Production Value by Application (2019-2024)
6.2.2 Global Empagliflozin API Production Value by Application (2025-2030)
6.2.3 Global Empagliflozin API Production Value Market Share by Application (2019-2030)
6.3 Global Empagliflozin API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Piramal Enterprises Limited
7.1.1 Piramal Enterprises Limited Empagliflozin API Corporation Information
7.1.2 Piramal Enterprises Limited Empagliflozin API Product Portfolio
7.1.3 Piramal Enterprises Limited Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Piramal Enterprises Limited Main Business and Markets Served
7.1.5 Piramal Enterprises Limited Recent Developments/Updates
7.2 Metrochem API Private Limited
7.2.1 Metrochem API Private Limited Empagliflozin API Corporation Information
7.2.2 Metrochem API Private Limited Empagliflozin API Product Portfolio
7.2.3 Metrochem API Private Limited Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Metrochem API Private Limited Main Business and Markets Served
7.2.5 Metrochem API Private Limited Recent Developments/Updates
7.3 ZCL Chemicals Limited
7.3.1 ZCL Chemicals Limited Empagliflozin API Corporation Information
7.3.2 ZCL Chemicals Limited Empagliflozin API Product Portfolio
7.3.3 ZCL Chemicals Limited Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 ZCL Chemicals Limited Main Business and Markets Served
7.3.5 ZCL Chemicals Limited Recent Developments/Updates
7.4 Dr. Reddy's Laboratories
7.4.1 Dr. Reddy's Laboratories Empagliflozin API Corporation Information
7.4.2 Dr. Reddy's Laboratories Empagliflozin API Product Portfolio
7.4.3 Dr. Reddy's Laboratories Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Teva Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
7.5.2 Teva Pharmaceutical Industries Ltd. Empagliflozin API Product Portfolio
7.5.3 Teva Pharmaceutical Industries Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
7.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
7.6.2 Sun Pharmaceutical Industries Ltd. Empagliflozin API Product Portfolio
7.6.3 Sun Pharmaceutical Industries Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.7 Hikal
7.7.1 Hikal Empagliflozin API Corporation Information
7.7.2 Hikal Empagliflozin API Product Portfolio
7.7.3 Hikal Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Hikal Main Business and Markets Served
7.7.5 Hikal Recent Developments/Updates
7.8 Morepen Laboratories
7.8.1 Morepen Laboratories Empagliflozin API Corporation Information
7.8.2 Morepen Laboratories Empagliflozin API Product Portfolio
7.8.3 Morepen Laboratories Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Morepen Laboratories Main Business and Markets Served
7.7.5 Morepen Laboratories Recent Developments/Updates
7.9 Zhejiang Huahai Pharmaceutial. Co., Ltd.
7.9.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Corporation Information
7.9.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Product Portfolio
7.9.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
7.9.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
7.10 Lupin Ltd
7.10.1 Lupin Ltd Empagliflozin API Corporation Information
7.10.2 Lupin Ltd Empagliflozin API Product Portfolio
7.10.3 Lupin Ltd Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Lupin Ltd Main Business and Markets Served
7.10.5 Lupin Ltd Recent Developments/Updates
7.11 Biocon Limited
7.11.1 Biocon Limited Empagliflozin API Corporation Information
7.11.2 Biocon Limited Empagliflozin API Product Portfolio
7.11.3 Biocon Limited Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Biocon Limited Main Business and Markets Served
7.11.5 Biocon Limited Recent Developments/Updates
7.12 Mehta API Pvt. Ltd
7.12.1 Mehta API Pvt. Ltd Empagliflozin API Corporation Information
7.12.2 Mehta API Pvt. Ltd Empagliflozin API Product Portfolio
7.12.3 Mehta API Pvt. Ltd Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Mehta API Pvt. Ltd Main Business and Markets Served
7.12.5 Mehta API Pvt. Ltd Recent Developments/Updates
7.13 Danesh Kimia Pharmed
7.13.1 Danesh Kimia Pharmed Empagliflozin API Corporation Information
7.13.2 Danesh Kimia Pharmed Empagliflozin API Product Portfolio
7.13.3 Danesh Kimia Pharmed Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Danesh Kimia Pharmed Main Business and Markets Served
7.13.5 Danesh Kimia Pharmed Recent Developments/Updates
7.14 Shandong Haohong Biotechnology Co., Ltd.
7.14.1 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Corporation Information
7.14.2 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Product Portfolio
7.14.3 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Shandong Haohong Biotechnology Co., Ltd. Main Business and Markets Served
7.14.5 Shandong Haohong Biotechnology Co., Ltd. Recent Developments/Updates
7.15 Boryung Pharmaceutical Co., Ltd
7.15.1 Boryung Pharmaceutical Co., Ltd Empagliflozin API Corporation Information
7.15.2 Boryung Pharmaceutical Co., Ltd Empagliflozin API Product Portfolio
7.15.3 Boryung Pharmaceutical Co., Ltd Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Boryung Pharmaceutical Co., Ltd Main Business and Markets Served
7.15.5 Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
7.16 Ami Lifesciences
7.16.1 Ami Lifesciences Empagliflozin API Corporation Information
7.16.2 Ami Lifesciences Empagliflozin API Product Portfolio
7.16.3 Ami Lifesciences Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Ami Lifesciences Main Business and Markets Served
7.16.5 Ami Lifesciences Recent Developments/Updates
7.17 Jiangsu Yutian Pharmaceutical Co., Ltd.
7.17.1 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Corporation Information
7.17.2 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Product Portfolio
7.17.3 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Jiangsu Yutian Pharmaceutical Co., Ltd. Main Business and Markets Served
7.17.5 Jiangsu Yutian Pharmaceutical Co., Ltd. Recent Developments/Updates
7.18 SGMR Pharmaceuticals
7.18.1 SGMR Pharmaceuticals Empagliflozin API Corporation Information
7.18.2 SGMR Pharmaceuticals Empagliflozin API Product Portfolio
7.18.3 SGMR Pharmaceuticals Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.18.4 SGMR Pharmaceuticals Main Business and Markets Served
7.18.5 SGMR Pharmaceuticals Recent Developments/Updates
7.19 Kopran Limited
7.19.1 Kopran Limited Empagliflozin API Corporation Information
7.19.2 Kopran Limited Empagliflozin API Product Portfolio
7.19.3 Kopran Limited Empagliflozin API Production, Value, Price and Gross Margin (2019-2024)
7.19.4 Kopran Limited Main Business and Markets Served
7.19.5 Kopran Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Empagliflozin API Industry Chain Analysis
8.2 Empagliflozin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Empagliflozin API Production Mode & Process
8.4 Empagliflozin API Sales and Marketing
8.4.1 Empagliflozin API Sales Channels
8.4.2 Empagliflozin API Distributors
8.5 Empagliflozin API Customers
9 Empagliflozin API Market Dynamics
9.1 Empagliflozin API Industry Trends
9.2 Empagliflozin API Market Drivers
9.3 Empagliflozin API Market Challenges
9.4 Empagliflozin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Empagliflozin API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Empagliflozin API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Empagliflozin API Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Empagliflozin API Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Empagliflozin API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Empagliflozin API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Empagliflozin API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Empagliflozin API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Empagliflozin API as of 2023)
Table 10. Global Market Empagliflozin API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Empagliflozin API Production Sites and Area Served
Table 12. Manufacturers Empagliflozin API Product Types
Table 13. Global Empagliflozin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Empagliflozin API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Empagliflozin API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Empagliflozin API Production Value Market Share by Region (2019-2024)
Table 18. Global Empagliflozin API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Empagliflozin API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Empagliflozin API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Empagliflozin API Production (Ton) by Region (2019-2024)
Table 22. Global Empagliflozin API Production Market Share by Region (2019-2024)
Table 23. Global Empagliflozin API Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Empagliflozin API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Empagliflozin API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Empagliflozin API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Empagliflozin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Empagliflozin API Consumption by Region (2019-2024) & (Ton)
Table 29. Global Empagliflozin API Consumption Market Share by Region (2019-2024)
Table 30. Global Empagliflozin API Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Empagliflozin API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Empagliflozin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Empagliflozin API Consumption by Country (2019-2024) & (Ton)
Table 34. North America Empagliflozin API Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Empagliflozin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Empagliflozin API Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Empagliflozin API Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Empagliflozin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Empagliflozin API Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Empagliflozin API Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Empagliflozin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Empagliflozin API Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Empagliflozin API Consumption by Country (2025-2030) & (Ton)
Table 44. Global Empagliflozin API Production (Ton) by Type (2019-2024)
Table 45. Global Empagliflozin API Production (Ton) by Type (2025-2030)
Table 46. Global Empagliflozin API Production Market Share by Type (2019-2024)
Table 47. Global Empagliflozin API Production Market Share by Type (2025-2030)
Table 48. Global Empagliflozin API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Empagliflozin API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Empagliflozin API Production Value Share by Type (2019-2024)
Table 51. Global Empagliflozin API Production Value Share by Type (2025-2030)
Table 52. Global Empagliflozin API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Empagliflozin API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Empagliflozin API Production (Ton) by Application (2019-2024)
Table 55. Global Empagliflozin API Production (Ton) by Application (2025-2030)
Table 56. Global Empagliflozin API Production Market Share by Application (2019-2024)
Table 57. Global Empagliflozin API Production Market Share by Application (2025-2030)
Table 58. Global Empagliflozin API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Empagliflozin API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Empagliflozin API Production Value Share by Application (2019-2024)
Table 61. Global Empagliflozin API Production Value Share by Application (2025-2030)
Table 62. Global Empagliflozin API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Empagliflozin API Price (US$/Ton) by Application (2025-2030)
Table 64. Piramal Enterprises Limited Empagliflozin API Corporation Information
Table 65. Piramal Enterprises Limited Specification and Application
Table 66. Piramal Enterprises Limited Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Piramal Enterprises Limited Main Business and Markets Served
Table 68. Piramal Enterprises Limited Recent Developments/Updates
Table 69. Metrochem API Private Limited Empagliflozin API Corporation Information
Table 70. Metrochem API Private Limited Specification and Application
Table 71. Metrochem API Private Limited Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Metrochem API Private Limited Main Business and Markets Served
Table 73. Metrochem API Private Limited Recent Developments/Updates
Table 74. ZCL Chemicals Limited Empagliflozin API Corporation Information
Table 75. ZCL Chemicals Limited Specification and Application
Table 76. ZCL Chemicals Limited Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. ZCL Chemicals Limited Main Business and Markets Served
Table 78. ZCL Chemicals Limited Recent Developments/Updates
Table 79. Dr. Reddy's Laboratories Empagliflozin API Corporation Information
Table 80. Dr. Reddy's Laboratories Specification and Application
Table 81. Dr. Reddy's Laboratories Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Dr. Reddy's Laboratories Main Business and Markets Served
Table 83. Dr. Reddy's Laboratories Recent Developments/Updates
Table 84. Teva Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
Table 85. Teva Pharmaceutical Industries Ltd. Specification and Application
Table 86. Teva Pharmaceutical Industries Ltd. Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
Table 88. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 89. Sun Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
Table 90. Sun Pharmaceutical Industries Ltd. Specification and Application
Table 91. Sun Pharmaceutical Industries Ltd. Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
Table 93. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 94. Hikal Empagliflozin API Corporation Information
Table 95. Hikal Specification and Application
Table 96. Hikal Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Hikal Main Business and Markets Served
Table 98. Hikal Recent Developments/Updates
Table 99. Morepen Laboratories Empagliflozin API Corporation Information
Table 100. Morepen Laboratories Specification and Application
Table 101. Morepen Laboratories Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Morepen Laboratories Main Business and Markets Served
Table 103. Morepen Laboratories Recent Developments/Updates
Table 104. Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Corporation Information
Table 105. Zhejiang Huahai Pharmaceutial. Co., Ltd. Specification and Application
Table 106. Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
Table 108. Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
Table 109. Lupin Ltd Empagliflozin API Corporation Information
Table 110. Lupin Ltd Specification and Application
Table 111. Lupin Ltd Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Lupin Ltd Main Business and Markets Served
Table 113. Lupin Ltd Recent Developments/Updates
Table 114. Biocon Limited Empagliflozin API Corporation Information
Table 115. Biocon Limited Specification and Application
Table 116. Biocon Limited Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Biocon Limited Main Business and Markets Served
Table 118. Biocon Limited Recent Developments/Updates
Table 119. Mehta API Pvt. Ltd Empagliflozin API Corporation Information
Table 120. Mehta API Pvt. Ltd Specification and Application
Table 121. Mehta API Pvt. Ltd Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Mehta API Pvt. Ltd Main Business and Markets Served
Table 123. Mehta API Pvt. Ltd Recent Developments/Updates
Table 124. Danesh Kimia Pharmed Empagliflozin API Corporation Information
Table 125. Danesh Kimia Pharmed Specification and Application
Table 126. Danesh Kimia Pharmed Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. Danesh Kimia Pharmed Main Business and Markets Served
Table 128. Danesh Kimia Pharmed Recent Developments/Updates
Table 129. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Corporation Information
Table 130. Shandong Haohong Biotechnology Co., Ltd. Specification and Application
Table 131. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 132. Shandong Haohong Biotechnology Co., Ltd. Main Business and Markets Served
Table 133. Shandong Haohong Biotechnology Co., Ltd. Recent Developments/Updates
Table 134. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Corporation Information
Table 135. Boryung Pharmaceutical Co., Ltd Specification and Application
Table 136. Boryung Pharmaceutical Co., Ltd Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 137. Boryung Pharmaceutical Co., Ltd Main Business and Markets Served
Table 138. Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
Table 139. Ami Lifesciences Empagliflozin API Corporation Information
Table 140. Ami Lifesciences Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 141. Ami Lifesciences Main Business and Markets Served
Table 142. Ami Lifesciences Recent Developments/Updates
Table 143. Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Corporation Information
Table 144. Jiangsu Yutian Pharmaceutical Co., Ltd. Specification and Application
Table 145. Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 146. Jiangsu Yutian Pharmaceutical Co., Ltd. Main Business and Markets Served
Table 147. Jiangsu Yutian Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 148. SGMR Pharmaceuticals Empagliflozin API Corporation Information
Table 149. SGMR Pharmaceuticals Specification and Application
Table 150. SGMR Pharmaceuticals Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 151. SGMR Pharmaceuticals Main Business and Markets Served
Table 152. SGMR Pharmaceuticals Recent Developments/Updates
Table 153. Kopran Limited Empagliflozin API Corporation Information
Table 154. Kopran Limited Specification and Application
Table 155. Kopran Limited Empagliflozin API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 156. Kopran Limited Main Business and Markets Served
Table 157. Kopran Limited Recent Developments/Updates
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Empagliflozin API Distributors List
Table 161. Empagliflozin API Customers List
Table 162. Empagliflozin API Market Trends
Table 163. Empagliflozin API Market Drivers
Table 164. Empagliflozin API Market Challenges
Table 165. Empagliflozin API Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Empagliflozin API
Figure 2. Global Empagliflozin API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Empagliflozin API Market Share by Type: 2023 VS 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Empagliflozin API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Empagliflozin API Market Share by Application: 2023 VS 2030
Figure 8. Empagliflozin Tablets
Figure 9. Others
Figure 10. Global Empagliflozin API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Empagliflozin API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Empagliflozin API Production Capacity (Ton) & (2019-2030)
Figure 13. Global Empagliflozin API Production (Ton) & (2019-2030)
Figure 14. Global Empagliflozin API Average Price (US$/Ton) & (2019-2030)
Figure 15. Empagliflozin API Report Years Considered
Figure 16. Empagliflozin API Production Share by Manufacturers in 2023
Figure 17. Empagliflozin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Empagliflozin API Revenue in 2023
Figure 19. Global Empagliflozin API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Empagliflozin API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Empagliflozin API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 22. Global Empagliflozin API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. India Empagliflozin API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. China Empagliflozin API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. South Korea Empagliflozin API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Israel Empagliflozin API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Empagliflozin API Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 28. Global Empagliflozin API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 30. North America Empagliflozin API Consumption Market Share by Country (2019-2030)
Figure 31. Canada Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 32. U.S. Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 33. Europe Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 34. Europe Empagliflozin API Consumption Market Share by Country (2019-2030)
Figure 35. Germany Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. France Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 37. U.K. Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 38. Italy Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. Russia Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. Asia Pacific Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 41. Asia Pacific Empagliflozin API Consumption Market Share by Regions (2019-2030)
Figure 42. China Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. Japan Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 44. South Korea Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 45. China Taiwan Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. Southeast Asia Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. India Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. Latin America, Middle East & Africa Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 49. Latin America, Middle East & Africa Empagliflozin API Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Brazil Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 52. Turkey Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 53. GCC Countries Empagliflozin API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 54. Global Production Market Share of Empagliflozin API by Type (2019-2030)
Figure 55. Global Production Value Market Share of Empagliflozin API by Type (2019-2030)
Figure 56. Global Empagliflozin API Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Production Market Share of Empagliflozin API by Application (2019-2030)
Figure 58. Global Production Value Market Share of Empagliflozin API by Application (2019-2030)
Figure 59. Global Empagliflozin API Price (US$/Ton) by Application (2019-2030)
Figure 60. Empagliflozin API Value Chain
Figure 61. Empagliflozin API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
